Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness
Forbes
Mon, 02/20/23 - 12:37 pm
Tags:
RSV, vaccines, GSK, Pfizer, Sanofi, Sobi, Moderna Therapeutics, AstraZeneca, JNJ, FDA
Sanofi and Regeneron face a high-risk test for Dupixent
EP Vantage
Fri, 02/17/23 - 10:20 am
Tags:
Sanofi, Regeneron, Dupixent, COPD, clinical trials
US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case
Endpoints
Mon, 02/13/23 - 10:12 pm
Tags:
Pfizer, Viatris, Sanofi, Regeneron, patents, Supreme Court
Reed relinquishes R&D reins at Sanofi to pursue new opportunity, sparking race to find successor
Fierce Biotech
Mon, 02/13/23 - 10:36 am
Tags:
R&D, Sanofi, John Reed
Dupixent kicks off 2023 as top pharma brand for ad impressions
Medical Devices and Diagnostics Industry
Mon, 02/6/23 - 06:13 pm
Tags:
Sanofi, Dupixent, asthma, pharma advertising
Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023
Fierce Pharma
Mon, 02/6/23 - 10:58 am
Tags:
Sanofi, Dupixent, earnings
Sanofi Admits Defeat for Myasthenia Gravis Candidate, Drops Phase III Trial
BioSpace
Fri, 02/3/23 - 10:31 am
Tags:
Sanofi, tolebrutinib, myasthenia gravis
New competitors push Sanofi to offer voluntary retirement packages at two Indian sites
Endpoints
Tue, 01/31/23 - 11:20 pm
Tags:
Sanofi, India, drug manufacturing
AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS
Endpoints
Mon, 01/30/23 - 05:58 pm
Tags:
AstraZeneca, Sanofi, Novo Nordisk, 340B, drug discounts
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
Tags:
television ads, pharma marketing, DTC ads, AbbVie, Rinvoq, Dupixent, Sanofi, Regeneron, Skyrizi, Novo Nordisk, Ozempic, Jardiance, Eli Lilly, Boehringer Ingelheim, Rybelsus, Trulicity, Rexulti, Otsuka, Lundbeck, Tremfya, JNJ, Verzenio
Sanofi dives deeper into phase 3 data for Hemlibra rival as FDA decision approaches
Fierce Biotech
Thu, 01/26/23 - 10:47 am
Tags:
Sanofi, FDA, clinical trials, hemophilia A, efanesoctocog alfa, Roche, Hemlibra
Sanofi takes to TikTok and Instagram to target millennials and older Gen Z parents for RSV education
Endpoints
Wed, 01/25/23 - 10:51 pm
Tags:
Sanofi, social media, TikTok, Instagram, RSV, pharma marketing
Sanofi promises money back for discontinued blood disorder treatment – in some cases
Endpoints
Mon, 01/23/23 - 10:00 pm
Tags:
Sanofi, drug warranty programs, Cablivi, aTTP
Sanofi and CytoReason target IBD in expanded collaboration
Pharma Live
Mon, 01/23/23 - 11:03 am
Tags:
Sanofi, CytoReason, IBD, R&D
JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor
BioPharma Dive
Wed, 01/11/23 - 11:08 pm
Tags:
JPMHC 2023, Takeda, Bristol Myers Squibb, Prime Medicine, Sanofi
Sanofi extends commitment to $750M biotech startup fund
Endpoints
Wed, 01/11/23 - 10:55 pm
Tags:
Sanofi, Sanofi Ventures, funding
JPM23: Sanofi has reached the 'steady state' Paul Hudson envisioned years ago, CEO says
Fierce Pharma
Wed, 01/11/23 - 10:54 am
Tags:
JPMHC 2023, Sanofi, Paul Hudson, Pharma CEOs, Dupixent
JPM Day 2: Highlights
BioSpace
Tue, 01/10/23 - 06:50 pm
Tags:
JPMHC 2023, Relay Therapeutics, Sanofi, Scholar Rock, SAGE Therapeutics, Karuna Therapeutics, GSK
What This Drug News Could Mean for Sanofi Shareholders
Motley Fool
Sun, 01/8/23 - 10:13 pm
Tags:
Sanofi, Dupixent
FDA starts review of Sanofi, AZ antibody for RSV prevention
Pharmaphorum
Thu, 01/5/23 - 10:20 am
Tags:
RSV, Sanofi, AstraZeneca, FDA, antibodies, nirsevimab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.